GENEVA, Sept. 7 -- FUNDACIÓ INSTITUT D'INVESTIGACIÓ BIOMÈDICA DE BELLVITGE (IDIBELL) filed a patent application (EP2026/055441) for “TREATMENT OF HEMATOPOIETIC STEM CELLS (HSC) AGING-RELATED DISEASES WITH RHOA INHIBITORS”. With publication no. WO/2026/180688, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/175
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....